This pilot study tests the drug ruxolitinib in people with advanced non-small cell lung cancer who are experiencing cancer cachexia—unintended weight loss and muscle wasting. The main goal is to check for side effects and see how the drug affects body signals related to appetite …
Phase: EARLY_PHASE1 • Sponsor: Tu Dan • Aim: Symptom relief
Last updated Jul 09, 2026 00:00 UTC